Skip to main content

Advertisement

Table 1 Characteristics of patients and controls

From: The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor

  Patients (n = 50) Controls (n = 40)
Age – years 53.1 (14.9) 50.3 (12.8)
Weight – kg 87.1 (16.5) -
Time after intake – minutes 130.1 (14.9) -
Platelet count – x 109/L 142.6 (54.7) 171.8 (54.3)
Platelet count in PRP – x 109/L 146.3 (44.5) 152.4 (26.0)
Rivaroxaban dose (mg od) 20 0
Sex (female) 26 (52%) 24 (60%)
Deep vein thrombosis 21 (42%) -
Pulmonary embolism 28 (56%) -
Atrial fibrillation 1 (2%) -
  1. Values are given in mean (SD) or n (%)